The core question of the study was whether the nerve-sparing status and surgical approach affected the patients' sexual life in the first year after surgery. In addition, determinants of erectile function (EF) and the extent of sexual activity were investigated. We conducted a multicentric, longitudinal study in seven German hospitals before, 3, 6 and 12 months after radical prostatectomy (RP). A total of 329 patients were asked to self-assess the symptoms associated with erectile dysfunction (ED). These symptoms were assessed using the International Index of Erectile Function and EORTC QLQ-PR25 questionnaires. A multiple regression model was used to test the influence of clinical, socio-demographic and quality-of-life-associated variables on the patients' EF 1 year after RP. Before surgery, 39% of patients had a severe ED (complete impotence). At 3, 6 and 12 months after surgery, it was 80, 79 and 71%, respectively. Although the surgical approach had no significant effect on EF, patients who had undergone nerve-sparing surgery had significantly lower ED rates. Nevertheless, 1 year after RP, 66% of these patients had severe ED. Age, nerve-sparing status and the burden of urinary symptoms had the greatest impact on the patients' EF. Regardless of nerve-sparing status and surgical approach, postsurgical improvement of EF does not mean a full convalescence of presurgical EF. Instead, it may rather reduce the degree of postsurgical ED in time. Consequently, urologists should disclose to the patient that ED is a likely side effect of RP.
INTRODUCTION
In many Western countries, prostate cancer has become the most frequently diagnosed cancer in the male population. In Germany, the current incidence is about 60 000 cases per year. 1 Since the introduction of prostate cancer screening, prostate cancer-specific incidence rates have doubled from approx. 50 per 100 000 in 1980 to approx. 100 in 2006. 2 Moreover, there has been a trend towards earlier-stage disease at presentation. 3, 4 If detected in a localised state, the most common treatment for prostate cancer is radical prostatectomy (RP). RP can be performed in several ways. The classical approach is open retropubic prostatectomy. Furthermore, RP can be performed in a minimalinvasive laparoscopic way. Both surgical approaches have excellent survival outcomes. In Germany, the 5-year relative survival rate for prostate cancer is between 83 and 94%. 1 However, there are also strong side effects of RP, for example, erectile dysfunction (ED). 5 Depending on the surgical technique, patient age and other sociodemographic and clinical factors, ED rates differ a lot. Even 1 year after RP, ED occurs in about 12--83% of patients. 5--8 The current study is the first prospective multicentre study to compare the functional results of patients who underwent either radical retropubic prostatectomy (RRPE) or endoscopic extraperitoneal radical prostatectomy (EERPE). In this paper, we report data related to the patients' sexual life before (t baseline ), 3 months (t 3m ), 6 months (t 6m ) and 1 year (t 1yr ) after prostatectomy.
The core question of the study was whether the nerve-sparing status and surgical approach had an effect on the patients' sexual life in the first year after surgery.
The preservation of neurovascular bundles is considered a prerequisite for regaining sexual function after surgery.
9,10
Thus, we expect significantly better sexual functioning in patients who had undergone nerve-sparing vs non-nerve-sparing surgery.
As studies comparing RRPE with transperitoneal laparoscopic radical prostatectomy (a surgical approach similar to EERPE) suggest that there are no differences between both surgical techniques in terms of functional results, 11 we do not expect significant differences between RRPE and EERPE regarding sexual function either.
In addition, the prevalence of ED before RP, determinants of erectile function (EF) and the extent of sexual activity (not restricted to sexual intercourse) were investigated. hospitals (one of the seven hospitals performed both EERPE and RRPE). Medical data were gathered from (electronic) patient records. At 3, 6 and 12 months after surgery, patients received a telephone call before the questionnaire was sent, asking them to continue their participation in the study. Patients who had still failed to respond 2 weeks after reception were once again contacted and asked to complete the questionnaire.
The study was restricted to men with a first-time diagnosis of localised prostate cancer. To prevent different surgeons' experience from biasing results, the two surgical methods were performed by two surgeons per centre with a personal experience of more than 200 cases in the past 5 years.
Written informed consent was obtained from all patients before their participation. The study was approved by the Ethics Committee of the University of Leipzig, Faculty of Medicine (Approval No. 219--2007) and has therefore been performed in accordance with ethical standards.
Patient characteristics
In total, 576 patients underwent RP. 89 patients had to be excluded from the study. 15 of which because of insuffient German knowledge and 19 because they could not be met by the recruiters. Furthermore, patients who had a pathological cancer stage of pT4 (N ¼ 4) and patients who answered the first questionnaire after surgery (N ¼ 51) were also excluded from the study.
Thus, 487 patients (237 EERPE and 250 RRPE) were eligible to participate in the study, of which 97 patients refused study participation at baseline. From 3 months to 1 year after surgery, further 61 patients did not answer the questionnaire.
In consequence, the total number of valid questionnaires returned was 329 (152 EERPE and 177 RRPE).
There were no statistically significant differences between respondents (study participants) and nonrespondents (patients who refused participation or excluded from the study) regarding age (65.3 vs 64.8 years) and pelvic lymph node dissection (75% vs 76%). Participation rates of EERPE patients and RRPE patients were also rather similar. The share of patients who underwent nerve-sparing surgery was significantly higher among respondents than among nonrespondents (64% vs 55%, Po0.05) (not in table) .
Patients who were completely impotent ('severe ED') before surgery were excluded from further analysis. Thus, socio-demographic and clinical baseline characteristics are presented separately for patients who are not impotent vs those who are impotent before surgery (see Table 1 ).
About 50% of patients were aged between 61 and 70 years (range: 45--81 years). Patients who were not impotent before surgery were significantly younger than preoperatively impotent patients (4.5 years) and had a partnership significantly more often. The proportion of pensioners was significantly larger among preoperatively impotent patients (see Table 1 ).
The proportion of patients who had undergone nerve-sparing surgery was significantly larger among patients who were not impotent before surgery. Preoperatively impotent patients had undergone lymph node dissection significantly more often (see Table 1 ).
Variables
The International Index of Erectile Function (IIEF) is a 15-item selfadministered questionnaire addressing five relevant aspects of male sexual function: erectile function (EF), orgasmic function (OF), sexual desire (SD), intercourse satisfaction (IS) and overall satisfaction (OS). Each of the scales has a different theoretical score range. Higher scores indicate better functioning or higher SD and satisfaction. 12, 13 Grades of ED severity were assessed according to a classification of Cappelleri et al.
14 The following score intervals indicate different severity grades of ED: 1--10 ¼ 'severe', 11--16 ¼ 'moderate', 17--21 ¼ 'mild-moderate', 22--25 ¼ 'mild' and 26--30 ¼ no ED. Owing to low case numbers in the score interval from 11 to 25, the 'mild', 'mild to moderate' and 'moderate' grades of ED severity were summarised into the category 'mild to moderate ED' in this paper.
The burden of urinary symptoms and depression were considered as potential factors influencing post-surgical erectile function. Urinary symptoms were evaluated using the urinary symptoms scale of the EORTC QLQ-PR25 questionnaire. 15 'Sexual activity' was measured with one item of the EORTC QLQ-PR25 questionnaire asking the patients, 'To what extent were you sexually active (with or without intercourse)?' Depression was assessed with the corresponding scale of the 'Hospital Anxiety and Depression Scale'. 16 
Analysis
Statistical analysis was conducted with PASW 18 and MS Excel 2003. Longitudinal differences in IIEF domains were calculated using repeated measures analysis of variance and paired t tests. Cross-sectional differences in severity grades of ED between the two treatment groups were assessed using Kendall's tau-b rank correlation coefficient. Because this study has explorative status, no correction for multiple testing was applied.
A multiple regression model was used to test the influence of clinical variables (surgical approach, nerve-sparing status), socio-demographic variables (age, education) and quality-of-life-associated variables (depression, burden of urinary symptoms) on the patients' EF 1 year after RP.
In Germany, PDE-5 inhibitors are usually prescribed by outpatient urologists. As a consequence, data about the medical treatment of ED could not be derived from the hospitals' patient records. Thus, this variable could not be included in the analysis.
RESULTS
Prevalence of ED before RP (N ¼ 329) During the 4 weeks before surgery, 36% of patients did not have any form of ED, 26% had a mild to moderate ED and 39% a severe ED. The proportion of patients with severe ED before RP was significantly larger among patients who had chosen RRPE vs EERPE (46 vs 30%).
Among the 202 patients who were not completely impotent before surgery, 149 (74%) received nerve-sparing RP (either unilateral or bilateral; see Table 1 ).
Results of nerve-sparing vs non-nerve-sparing RP (N ¼ 202) As this chapter examines the impact of RP on postoperative sexual life, patients who were completely impotent (severe ED) even before surgery were excluded from analysis. Thus, 202 (149 nerve-sparing vs 53 non-nerve-sparing) patients were included in the analysis.
Erectile function
Of the 202 patients not completely impotent before RP, 59% had no symptoms of ED and 41% had a mild to moderate form of ED. After 3 months of RP, the patients' EF had significantly reduced. At t 3m , 80% of patients had a 'severe' form of ED. Thus, the postoperative reduction of EF from t baseline to t 3m must be considered clinically meaningful. This reduction was significantly stronger in patients who underwent non-nerve-sparing vs nerve-sparing RP. However, even 76% of patients who had undergone nerve-sparing RP had a severe ED 3 months after surgery (see Table 2 ).
From t 3m to t 6m , no statistically significant improvements of EF could be measured. Nevertheless, 76% and 89% of patients had a 'severe' form of ED (nerve-sparing vs non-nerve-sparing). However, patients who had undergone nerve-sparing RP had significantly higher EF scores at t 6m than patients who had undergone non-nerve-sparing RP (Po0.05).
From t 6m to t 1yr , a statistically significant but small improvement of EF occurred in patients who had undergone nerve-sparing RP (Po0.05). However, even 1 year after nerve-sparing RP, 2/3 of patients had a severe form of ED. The improvement of EF in patients who had undergone non-nerve-sparing RP was even lower and not statistically significant.
Orgasmic function
The patients' orgasmic function strongly reduced from t baseline to t 3m . In patients who had undergone non-nerve-sparing RP, this reduction was significantly stronger than that in patients whose neurovascular bundles could be preserved. However, regardless of the nerve-sparing status, there were no statistically significant improvements in the course of time (from t 3m to t 1yr ) (see Figure 1 ).
Intercourse satisfaction
Regardless of the nerve-sparing status, 'satisfaction with sexual intercourse' had significantly reduced from t baseline to t 3m . However, the reduction in IS was significantly stronger in patients who had undergone non-nerve-sparing vs nerve-sparing RP. From t 3m to t 1yr , no significant improvement could be assessed.
Overall satisfaction Regardless of the nerve-sparing status, 'overall satisfaction' had significantly reduced from t baseline to t 3m . From t 3m to t 1yr , no significant improvement could be assessed. There were no significant differences between patients who had undergone non-nervesparing vs nerve-sparing RP.
Sexual desire With regard to the patients' SD, there was a small but statistically significant reduction form t baseline to t 3m . This reduction was slightly stronger in patients who had undergone non-nerve-sparing vs nerve-sparing RP. From t 3m to t 1yr , there were no significant changes in SD (see Figure 1) . Abbreviations: t 3m , 3 months after surgery; t 6m, 6 months after surgery; t 1yr , 1 year after surgery.
Determinants of erectile function 1 year after RP (N ¼ 202) A multiple regression model was used to test the influence of several factors on the patients' EF 1 year after RP. As potential factors, we considered the surgical approach (EERPE vs RRPE), nerve-sparing status, age and education, as well as the burden of urinary symptoms and depression 1 year after RP. The model had an adjusted R 2 of 0.17. Age, nerve-sparing status and the burden of urinary symptoms had the greatest impact on the patients' EF. Younger age (b ¼ À0.24, Po0.001), nerve-sparing vs non-nerve-sparing RP (b ¼ 0.21, Po0.001) and low urinary symptoms (b ¼ À0.14, P ¼ 0.027*) predict better EF 1 year after surgery.
Surgical approach (EERPE vs RRPE), education and depressivity (according to HAD scale) had no statistically significant impact on the patients' EF (P40.05).
Sexual activity after RP (N ¼ 202)
According to the EORTC QLQ-PR25 questionnaire, the proportion of patients being totally sexually inactive had reduced from 32.7% 3 months after surgery to 27.3% and 24.7% 6 months and 1 year after surgery, respectively. At the same time, the share of patients who showed 'a little' sexual activity changed from 26.1% to 25.8% and 34.3%. The proportion of patients being either 'quite a bit' or 'very much' sexually active remained relatively constant over time (t 3m, 41.2%; t 6m, 47.0%; t 1yr , 40.9%).
Results of nerve-sparing EERPE vs nerve-sparing RRPE (N ¼ 149) As this chapter examines the impact of nerve-sparing EERPE vs nerve-sparing RRPE on postoperative EF, patients who were completely impotent (severe ED) before surgery and patients who Figure 1 . IIEF domains after nerve-sparing vs. non-nerve-sparing RP (N ¼ 202). t baseline ¼ before surgery, t 3m ¼ 3 months after surgery, t 6m ¼ 6 months after surgery, t 1yr ¼ 1 year after surgery.
had undergone non-nerve-sparing surgery were excluded from analysis. Thus, 149 (71 EERPE vs 78 RRPE) patients were included in the analysis.
With regard to severity grades of ED, there were no statistically significant differences between nerve-sparing EERPE and RRPE in course of time (see Figure 2 ; Kendall's tau-b, P40.05).
With regard to orgasmic function, SD, intercourse and overall satisfaction, there were no clinically important improvements in course of time (from t 3m to t 1yr ) in patients who had undergone either EERPE or RRPE (not in Figure) .
DISCUSSION
With 39% (severe ED), the presurgical impotence rate of the current study seems to be rather high. However, considering the fact that about 11--55% 17, 18 of the male general population aged between 60 and 69 years have some form of ED (minimal, moderate or severe) and that diagnosis of cancer may lead to complete sexual abstinence even before surgery, 5 a preoperative ED rate of 39% seems to be realistic. Nevertheless, in most clinical trials on EF after RP the presurgical ED rate is 0%. 19 However, our results are consistent with those of other studies, which report presurgical ED rates from 27% to 58%. 20--22 Our data show that nerve-sparing EERPE and nerve-sparing RRPE offer similar outcomes in terms of EF 3, 6 and 12 months after surgery. Between the two surgical approaches, no statistically significant differences could be assessed. This outcome is in agreement with Anastasiadis' findings, which suggest that there are no significant differences between open retropubic and transperitoneal laparoscopic RP regarding functional outcome. 23 As shown in several other studies, patients who had undergone nerve-sparing RP have a greater chance to regain sexual function than patients who had undergone non-nerve-sparing RP. 9, 10, 24 However, even 1 year after nerve-sparing RP, 66% of patients had a severe form of ED, 27% of patients had regained at least some degree of EF and only 7% of patients had regained full EF. Thus, postsurgical improvement of EF does not mean a full convalescence of presurgical EF. Instead, it may rather reduce the degree of postsurgical ED in time. These results are consistent with those of McCullough, who found 'that few men experience potency that is as good postoperatively as it was preoperatively'. 25 In addition to the preservation of neurovascular bundles, the results of the current study indicate that younger age and a low burden of urinary symptoms also predict a better convalescence of EF 1 year after RP. In this context, urinary continence seems to be a prerequisite for having sexual intercourse.
However, the small and nonsignificant differences between patients who had undergone nerve sparing vs non-nerve-sparing RP regarding overall satisfaction with sexual life may indicate that EF is not necessarily a prerequisite for sexuality and intimacy, respectively. The following quote from a patient's questionnaire supports this idea: 'Sexuality seems to be too much restricted on coitus (in your questionnaire). My wife and me are very tender with each other. There is much more tenderness than with my former wife, although I did not have ejaculation problems back then.' Thus, for the evaluation of sexuality after RP, questionnaires and items not restricting sexuality to mere EF should also be considered. In this context, the EORTC QLQ-PR25 questionnaire seems to be more appropriate to measure the quality of life related to sexuality. Analysis showed that far more patients were actually sexually active than the IIEF score suggests.
According to McCullough, patients tend to assume that nerve sparing is synonymous with preservation of potency. In fact, only a few patients experience potency that is as good postoperatively as it was preoperatively. 25 Consequently, urologists should disclose to the patient that ED is likely to be a side effect not only of nonnerve-sparing but also of nerve-sparing RP.
As PDE-5 inhibitors are usually prescribed by outpatient urologists in Germany, no reliable information about postoperative drug use could be gathered. This must be considered a limitation of the study. Figure 2 . Erectile dysfunction status after nerve-sparing EERPE vs. nerve-sparing RRPE (N ¼ 149). t 3m ¼ 3 months after surgery, t 6m ¼ 6 months after surgery, t 1yr ¼ 1 year after surgery, nsEERPE ¼ nervesparing Endoscopic Extraperitoneal Radical Prostatectomy, nsRRPE ¼ nerve-sparing Radical Retropubic Prostatectomy.
